American biopharmaceutical services company with its head office at Morrisville in North Carolina, formed in 2017 by the merger of INC Research and inVentiv Health and taken private by an investor consortium in 2023, working in more than a hundred countries. Runs full service clinical development as a contract research organisation across all phases and therapeutic areas together with commercial services, so it handles protocol design, site selection and monitoring, data management and biostatistics, medical writing and regulatory submissions, pharmacovigilance and medical affairs, market access, field sales teams and product launches for medicine and device makers.
Aucun commentaire disponible.
Laissez votre note & commentaire